Notes on the Use of Fluvoxamine as Treatment of Depression in HIV-1-Infected Subjects

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Pharmacopsychiatry

• Publication date

  1995-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1055/s-2007-979597PMID 7568371
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Severe bradycardia following fluoxetine administration: A case report in a young HIV‐1 infected woman

  1995cited by this paper
• Use of Psychotropic Drugs in Patients with HIV Infection

  1994cited by this paper
• Prescription-Event Monitoring of 10401 Patients Treated with Fluvoxamine

  1994cited by this paper
• Caution with use of tricyclics in patients with AIDS.

  1991cited by this paper
• Fluoxetine treatment of depression in patients with HIV infection.

  1991cited by this paper
• A report of eight HIV-seropositive patients with major depression responding to fluoxetine.

  1990cited by this paper
• Dothiepin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness.

  1989cited by this paper
• Fluvoxamine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness.

  1986cited by this paper

• Factors associated with violent offenders with mental illness in forensic psychiatric evaluations

  2025cites this paper
• Antiretrovirals and Psychotropics: Drug Interactions and Complications

  2021cites this paper
• Psychiatry and Neurology

  2019cites this paper
• A Complex Case of Psychiatric Issues Associated with HIV Disorder

  2018cites this paper
• Drug–drug interactions and clinical considerations with co-administration of antiretrovirals and psychotropic drugs

  2018cites this paper
• Anxiety and Depression among People Living with HIV/AIDS Enrolled in Antiretroviral Treatment in AIDS Healthcare Foundation in Yeka Clinic

  2017cites this paper
• Pellagra and alcoholism: a biochemical perspective.

  2014cites this paper
• Characterization of functional polymorphisms and glucocorticoid-responsive elements in the promoter of TDO2, a candidate gene for ethanol-induced behavioural disorders.

  2013cites this paper
• Organische psychische Störungen bei wichtigen somatischen Erkrankungen

  2008cites this paper
• WITHDRAWN: Antidepressants for depression in medical illness.

  2007cites this paper
• The association between alcohol misuse and suicidal behaviour.

  2006cites this paper
• [Clinical features, diagnosis and treatment of HIV-induced neuropsychiatric disorders].

  2006cites this paper
• Klinik, Diagnostik und Therapie HIV-induzierter neuropsychiatrischer Störungen

  2006cites this paper
• Efficacy of Antidepressant Medication among HIV-Positive Individuals with Depression: A Systematic Review and Meta-Analysis

  2005cites this paper
• Ten Myths About HIV Infection and Aids

  2005cites this paper
• Use of Selective Serotonin-Reuptake Inhibitors in the Treatment of Depression in Adults with HIV

  2005cites this paper
• Depression in Children with HIV Infection: A Case Series.

  2005cites this paper
• Clinical management of depression and anxiety in HIV-infected adults

  2005cites this paper
• Making Advances Where It Matters: Improving Outcomes in Mood and Anxiety Disorders

  2004cites this paper
• Comorbidity of depression with other medical diseases in the elderly.

  2002cites this paper
• Practical psychopharmacology in HIV-1 and acquired immunodeficiency syndrome.

  2002cites this paper
• Serotonin-selektive Antidepressiva(SSRI, DSA)

  2002cites this paper
• Depression among Patients with HIV/AIDS: A Treatment Dilemma

  2001cites this paper
• Alcohol-induced euphoria: exclusion of serotonin.

  2001cites this paper
• Depression in patients with HIV infection.

  2000cites this paper
• Living and dying with HIV/AIDS: A psychosocial perspective.

  2000cites this paper
• Antidepressants for depression in medical illness.

  2000cites this paper
• Treatment of depression in patients with human immunodeficiency virus infection

  1999cites this paper
• Treatment of major depression in HIV-seropositive men. HIV Neurobehavioral Research Center Group.

  1998cites this paper
• Randomized, placebo-controlled trial of paroxetine versus imipramine in depressed HIV-positive outpatients.

  1998cites this paper
• Severe Diarrhoea in an HIV‐infected Patient with Chronic Hepatitis B Treated with Imipramine

  1997cites this paper
• Aspectos neuropsiquiátricos de la infección por VIH: un estudio de psiquiatría de enlace

  1997cites this paper
• Efficacy of paroxetine for the treatment of depression in the context of HIV infection.

  1997cites this paper
• Efficacy of Paroxetine for the Treatment of Depression in the Context of HIV Infection

  1997cites this paper
• Pharmacotherapy of HIV Dementia

  1997cites this paper
• Neuropsychiatric aspects of HIV infection: a liaison psychiatry study

  1997cites this paper